Free Access
Volume 25, Number 2, Mars 2016
Page(s) 168 - 177
Section Mise Au Point / Update
Published online 03 February 2016
  • Moran AE, Forouzanfar MH, Roth GA, et al (2014) The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation 129:1493–501 [CrossRef] [PubMed] [Google Scholar]
  • Ginks WR, Sybers HD, Maroko PR, et al (1972) Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest 51:2717–23 [CrossRef] [PubMed] [Google Scholar]
  • Braunwald E (2014) The ten advances that have defined modern cardiology. Trends cardiovasc Med 24:179–83 [CrossRef] [PubMed] [Google Scholar]
  • Hausenloy DL, Bøtker HE, Condorelli G, et al (2013) Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 98:7–27 [CrossRef] [PubMed] [Google Scholar]
  • Braunwald E, Kloner RA (1985) Myocardial reperfusion: a double-edged sword? J Clin Invest 76:1713–9 [CrossRef] [PubMed] [Google Scholar]
  • Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357:1121–35 [CrossRef] [PubMed] [Google Scholar]
  • Cour M, Gomez L, Mewton N, et al (2011) Postconditioning: from the bench to bedside. J Cardiovasc Pharmacol Ther 16:117–30 [CrossRef] [PubMed] [Google Scholar]
  • Friedrich MG, Abdel-Aty H, Taylor J, et al (2008) The salvage area at risk in reperfused acute myocardial infarction as visualised by cardiovascular magnetic resonance. J Am Coll Cardiol 51:1581–7 [CrossRef] [PubMed] [Google Scholar]
  • Chien GL, Wolff RA, Davis RF (1994) “Normothermic range” temperature affects myocardial infarct size. Cardiovasc Res 23:1014–7 [CrossRef] [Google Scholar]
  • Halestrap AP, Clarke SJ, Javadov SA (2004) Mitochondrial permeability transition pore: a target for cardioprotection. Cardiovasc Res 61:372–85 [CrossRef] [PubMed] [Google Scholar]
  • Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–36 [CrossRef] [PubMed] [Google Scholar]
  • Reimer KA, Murry CE, Yamasawa I, et al (1986) Four briefs periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 215:H1306–H15 [Google Scholar]
  • Yellon DM, Downey JM (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83:429–37 [CrossRef] [Google Scholar]
  • Kloner RA, Shook T, Przyklenk K, et al (1995) Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 91:37–45 [CrossRef] [PubMed] [Google Scholar]
  • Laskey WK (1999) Beneficial impact of preconditioning during PTCA on creatine kinase release. Circulation 99:2085–9 [CrossRef] [PubMed] [Google Scholar]
  • Argaud L, Rioufol G, Lièvre M, et al (2004) Preconditioning during coronary angioplasty: no influence of collateral perfusion on the size of the area at risk. Eur Heart J 2:2019–25 [CrossRef] [Google Scholar]
  • Walsh SR, Tang TY, Kullar P, et al (2008) Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomized clinical trials. Eur J Cardiothorac Surg 34:985–94 [CrossRef] [PubMed] [Google Scholar]
  • Przyklenk K, Bauer B, Ovize M, et al (1993) Regional ischemic “preconditioning” protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87:893–9 [CrossRef] [PubMed] [Google Scholar]
  • Heusch G, Bøtker HE, Przyklenk K, et al (2015) Remote ischemic conditioning. J Am Coll Cardiol 65:177–95 [CrossRef] [PubMed] [Google Scholar]
  • Schmidt MR, Smerup M, Konstantinov IE, et al (2007) Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. Am J Physiol Heart Circ Physiol 292:H1883–H90 [CrossRef] [PubMed] [Google Scholar]
  • Bøtker HE, Kharbanda R, Schmidt MR, et al (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375:727–34 [CrossRef] [PubMed] [Google Scholar]
  • Rentoukas I, Giannopoulos G, Kaoukis A, et al (2010) Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. J Am Coll Cardiol Intv 3:49–55 [CrossRef] [Google Scholar]
  • Munk K, Andersen NH, Schmidt MR, et al (2010) Remote ischemic conditioning in patients with angioplasty: impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT. Circ Cardiovasc Imaging 3:656–62 [CrossRef] [PubMed] [Google Scholar]
  • Yellon DM, Ackbarkhan AK, Balgobin V, et al (2015) Remote ischemic conditioning reduces myocardial infarct size in STEMI patients treated by thrombolysis. J Am Coll Cardiol 65:2764–5 [CrossRef] [PubMed] [Google Scholar]
  • Zhao ZQ, Corvera JS, Halkos ME, et al (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285:H579–H88 [CrossRef] [PubMed] [Google Scholar]
  • Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post- and remote conditioning. Circ Res 116:674–9 [CrossRef] [Google Scholar]
  • Staat P, Rioufol G, Piot C, et al (2005) Postconditioning the human heart. Circulation 112:2143–8 [CrossRef] [PubMed] [Google Scholar]
  • Thibault H, Piot C, Staat P, et al (2008) Long-term benefit of postconditioning. Circulation 117:1037–44 [CrossRef] [PubMed] [Google Scholar]
  • Zhou C, Yao Y, Zheng Z et al (2012) Stenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trials. Eur Heart J 33:2070–7 [CrossRef] [Google Scholar]
  • Hausenloy DJ, Maddock HL, Baxter GF, et al (2002) Inhibiting permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55:534–43 [CrossRef] [PubMed] [Google Scholar]
  • Argaud L, Gateau-Roesch O, Raisky O, et al (2005) Postconditioning inhibits mitochondrial permeability transition. Circulation 111:194–7 [CrossRef] [PubMed] [Google Scholar]
  • Argaud L, Gateau-Roesch O, Muntean D, et al (2005) Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 38:367–74 [CrossRef] [PubMed] [Google Scholar]
  • Piot C, Croisille P, Staat P, et al (2008) Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359:473–81 [CrossRef] [PubMed] [Google Scholar]
  • Mewton N, Croisille P, Gahide G, et al (2010) Effect of cyclosporine on left ventricular remodelling after reperfused myocardial infarction. J Am Coll Cardiol 55:1200–5 [CrossRef] [PubMed] [Google Scholar]
  • Cung TT, Morel O, Cayla G, et al (2015) Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med 373:1021–31 [CrossRef] [PubMed] [Google Scholar]
  • Latini R, Limbruno U, La Vecchia L, et al (2014) Abstract 15211: effect of cyclosporine A on infarct size reduction on reperfused acute myocardial infarction treated with primary angioplasty. Circulation 130:115211 [Google Scholar]
  • Chiari P, Angoulvant D, Mewton N, et al (2014) Cyclosporine protects the heart during aortic valve surgery. Anesthesiology 121:232–8 [CrossRef] [PubMed] [Google Scholar]
  • Hausenloy DJ, Kunst G, Boston-Griffith E, et al (2014) The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial. Heart 100:544–9 [CrossRef] [PubMed] [Google Scholar]
  • Nighoghossian N, Berthezène Y, Mechtouff L, et al (2015) Cyclosporine in acute ischemic stroke. Neurology 84:2216–23 [CrossRef] [PubMed] [Google Scholar]
  • Kloner RA (2013) Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Circ Res 113:451–63 [CrossRef] [PubMed] [Google Scholar]
  • The EMIP-FR Group, European Myocardial Infarction Project, Free Radicals (2000) Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy: a double-blind, placebo-controlled, randomized trial. Eur Heart J 21:1537–46 [CrossRef] [PubMed] [Google Scholar]
  • Zeymer U, Suryapranata H, Monassier JP, et al (2001) The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol 38:1644–50 [CrossRef] [PubMed] [Google Scholar]
  • Magnesium in Coronaries (MAGIC) Trial Investigators (2002) Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet 360:1189–96 [CrossRef] [PubMed] [Google Scholar]
  • Mehta SR, Yusuf S, Díaz R, et al (2005) Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293:437–46 [CrossRef] [PubMed] [Google Scholar]
  • Kloner RA, Forman MB, Gibbons RJ, et al (2006) Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J 27:2400–5 [CrossRef] [PubMed] [Google Scholar]
  • Kitakaze M, Asakura M, Kim J, et al (2007) Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet 370:1483–93 [CrossRef] [PubMed] [Google Scholar]
  • APEX AMI Investigators (2007) Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 297:43–51 [CrossRef] [PubMed] [Google Scholar]
  • Atar D, Petzelbauer P, Schwitter J, et al (2009) Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the FIRE. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 53:720–9 [CrossRef] [PubMed] [Google Scholar]
  • Voors AA, Belonje AM, Zijlstra F, et al (2010) A single dose of erythropoietin in ST elevation myocardial infarction. Eur Heart J 31:2593–600 [CrossRef] [PubMed] [Google Scholar]
  • Lønborg J, Vejlstrup N, Kelbæk H, et al (2012) Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J 33:1491–9 [CrossRef] [PubMed] [Google Scholar]
  • Ibanez B, Macaya C, Sanchez-Brunete V, et al (2013) Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) trial. Circulation 128:1495–503 [CrossRef] [PubMed] [Google Scholar]
  • Siddiqi N, Neil C, Bruce M, MacLennan G, et al (2014) Intravenous sodium nitrite in acute ST elevation myocardial infarction: a randomized controlled trial (NIAMI). Eur Heart J 35:1255–62 [CrossRef] [PubMed] [Google Scholar]
  • Ibanez B, Prat-González S, Speidl WS, et al (2007) Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 115:2909–16 [CrossRef] [PubMed] [Google Scholar]
  • Tissier R, Ghaleh B, Cohen MV, et al (2012) Myocardial protection with mild hypothermia. Cardiovasc Res 94:217–25 [CrossRef] [PubMed] [Google Scholar]
  • Cour M, Jahandiez V, Loufouat J, et al (2015) Minor changes in core temperature prior to cardiac arrest influence outcomes: an experimental study. J Cardiovasc Pharmacol Ther 20:407–13 [CrossRef] [PubMed] [Google Scholar]
  • Kandzari DE, Chu A, Brodie BR, et al (2004) Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study). Am J Cardiol 93:636–9 [CrossRef] [PubMed] [Google Scholar]
  • Dixon SR, Whitbourn RJ, Dae MW, et al (2002) Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial intervention. J Am Coll Cardiol 40:1928–34 [CrossRef] [PubMed] [Google Scholar]
  • Götberg M, Olivecrona GK, Koul S, et al (2010) A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction. Circ Cardiovasc Interv 3:400–7 [CrossRef] [PubMed] [Google Scholar]
  • Erlinge D, Götberg M, Noc M, et al (2014) Rapid endovascular core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. The CHILL-MI trial: a randomized controlled study of the use of central venous catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. J Am Coll Cardiol 63:1857–65 [CrossRef] [PubMed] [Google Scholar]
  • Cour M, Loufouat J, Paillard M, et al (2011) Inhibition of mitochondrial permeability transition to prevent the post-cardiac arrest syndrome: a preclinical study. Eur Heart J 32:226–35 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.